Clinical Trials Directory

Trials / Completed

CompletedNCT05836467

Is Myocardial Revascularization Really Necessary in Patients With ≥50-70% Coronary Stenosis Undergoing Valvular Surgery?

Status
Completed
Phase
Study type
Observational
Enrollment
77 (actual)
Sponsor
Michele De Bonis · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

It is well documented in the literature that myocardial revascularization during valve surgery increases the risk of early mortality and morbidity. According to the most recent version of the European Guidelines, the possibility of myocardial revascularization via coronary artery bypass should be evaluated in patients with an indication for surgical treatment of heart valve disease but with coronary artery stenosis ≥ 50-70%. In this study, patients hospitalized for surgical heart valve disease, with occasional pre-operative finding of ≥ 50-70% coronary artery stenosis, without angina, are examined. After interdisciplinary discussion in the Heart Team, it was decided not to treat coronary artery disease during valve surgery. The aim is to evaluate the short and medium-term results of this "conscious omission".

Conditions

Interventions

TypeNameDescription
PROCEDUREValvular interventionsAny kind of intervention on heart valves

Timeline

Start date
2019-10-05
Primary completion
2019-10-15
Completion
2019-10-15
First posted
2023-05-01
Last updated
2023-05-01

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05836467. Inclusion in this directory is not an endorsement.